Source link : https://newshealth.biz/health-news/nivolumab-ipilimumab-not-cost-effective-for-liver-cancer/
Researchers assess the cost‐effectiveness of nivolumab plus ipilimumab vs lenvatinib or sorafenib for hepatocellular carcinoma from a US healthcare payer perspective. Medscape Medical News Source link : https://www.medscape.com/viewarticle/nivolumab-ipilimumab-not-cost-effective-liver-cancer-2026a10003mp?src=rss Author : Publish date : 2026-02-05 04:03:00 Copyright for syndicated content belongs to the linked Source.
The post Nivolumab-Ipilimumab Not Cost-Effective for Liver Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2026-02-05 04:03:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8